-
VERAXA Biotech Announces Regulatory Progress with its BiTAC®-TCE Development Plan
ZURICH, SWITZERLAND – July 20, 2026 – VERAXA Biotech AG (NASDAQ: VRXA; “VERAXA), an emerging leader in designing novel cancer therapies, today announced that it has received Scientific Advice from the German regulatory authority, the Paul-Ehrlich-Institute (PEI), regarding the underlying biology and proposed non-clinical development plan for its most-advanced development program based on its proprietary…
-
Cosmos Health Share Buyback Surpasses $1 Million, Reaching 4.84 Million Shares; Continues Open Market Repurchases
CHICAGO, July 16, 2026 (GLOBE NEWSWIRE) — Cosmos Health Inc. (“Cosmos Health” or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that it has repurchased an additional 250,000 shares of its common stock in the open market at an average price of approximately $0.2782 per share. The Company has now repurchased a…
-
IMG Opens Applications for 2026 Fall Semester ‘Student Journey Scholarship’
INDIANAPOLIS, July 13, 2026 /PRNewswire/ — IMG (International Medical Group) is now accepting applications for its Student Journey Scholarship, a program designed to help international students fund their studies at a U.S. college or university. Entries for the 2026 Fall semester will be accepted July 13-October 4, 2026, and one student will be selected to…
-
GuideAI Health Announces Marketing and Communications Programs
July 10, 2026 17:01 ET | Source: GuideAI Health Corp. BOSTON, July 10, 2026 (GLOBE NEWSWIRE) — GuideAI Health Corp. (Cboe CA: GDAI) (“GuideAI” or the “Company“) is pleased to announce that it has engaged Upswitch Media Corp. (“Upswitch”) and BTV-Business Television (“BTV”) — to execute a coordinated marketing, communications and investor-awareness program (the “Program”). The…
-
Zealand Pharma – Transactions related to share buy-back program (week 27, 2026)
Company announcement No. 31 / 2026 Zealand Pharma – Transactions related to share buy-back program (week 27, 2026) Copenhagen, Denmark, July 6, 2026 – Zealand Pharma A/S (“the Company” or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company transforming the future of metabolic health, today reports transactions related to its share buy-back program (the…
-
Appili Therapeutics Announces Receipt from NIAID of a Notice of Termination for Convenience on the Contract for the VXV-01 Program
HALIFAX, Nova Scotia, July 03, 2026 (GLOBE NEWSWIRE) — Appili Therapeutics Inc. (TSX: APLI; OTCPink: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases today announced that it has received a Notice of Termination for Convenience from the National Institute of Allergy and Infectious Diseases (“NIAID”), part of the…
-
Morepen Starts Commercial Supplies Under its Rs. 825 Crore CDMO Mandate; First Rs. 50 Crore Dispatch Already Completed in Q1FY2026-27
Gurugram, Haryana, India Morepen Laboratories Limited (NSE: MOREPENLAB; BSE: 500288) today issued an update on its recently announced Rs. 825 crore CDMO mandate. The first commercial dispatch, valued at approximately Rs. 50 crore, has already been completed by the company under the program during Q1FY2026-27. This marks the successful transition of the mandate from validation…
-
ISRO Scientists Launch Space Technology & Research Program 2026 at Chandigarh University
CU Space Program to offer training & research by ISRO, IIST Scientists for research scholars and students CHANDIGARH, India, June 16, 2026 /PRNewswire/ — In a major step towards strengthening space technology education and research, Chandigarh University, through its Kalpana Chawla Centre (KCC) has launched the KCC Space Technology & Research Program 2026 and the KCC…
-
As 'Substandard' Medicine Alerts Rise Sharply, Medkart Pharmacy Promotes Radical Transparency
With India’s drug regulator flagging a record number of medicines as ‘Not of Standard Quality’ in 2025, Medkart spotlights its Medkart Assured program – independent plant audits, dual third-party lab testing, and a pledge to publish its own quality data Ahmedabad, Gujarat, India Medicine quality has become one of the country’s most closely watched health…
-
Commure Named “Overall NLP Company of the Year” in 2026 AI Breakthrough Awards
MOUNTAIN VIEW, Calif., June 25, 2026 (GLOBE NEWSWIRE) — Commure, a leading healthcare technology company, today announced it has been named “Overall NLP Company of the Year” in the 2026 AI Breakthrough Awards. The annual awards program recognizes the world’s most innovative companies, technologies, and products in artificial intelligence. Selected from more than 5,000 nominations…
-
TACO BELL® LAUNCHES L.O.C.O.S., ITS FIRST EMOTIONAL SUPPORT TACO PLATFORM FOR FANS IN THEIR FEELS
Debuting during this summer’s biggest sports stage, L.O.C.O.S. (Loss Or Celebration Outcome Support) rewards fans with tacos when they need them most, turning culture’s biggest wins and losses into a global emotional support taco program. TLDR: From celebrating a win to days that go fully off the rails, fans already turn to Taco Bell when…
-
Piramal Pharma Solutions Highlights Strong Performance Across More Than 200 Customer Audits
Piramal Pharma Solutions completed more than 200 customer audits and received over 70 approvals from regulatory agencies across its global network over the past year, with strong overall outcomes. This milestone reflects the Company’s long-range quality strategy focused on sustained compliance, continuous audit readiness, and operational effectiveness. Through robust governance, quality culture initiatives, workforce development, and…
-
MoonLake Announces Week 52 Results of Sonelokimab from its Phase 3 VELA Program in Hidradenitis Suppurativa and Confirms Investor Day on June 22, 2026
Results from the Phase 3 VELA clinical trials at Week 52 in adults with moderate-to-severe hidradenitis suppurativa (HS) demonstrate sonelokimab’s (SLK) potential best-in-class and best-in-disease profile, with consistent responses that are higher than those observed in trials of competing agents at the end of their respective parental trials Namely, ~67% of patients treated with SLK…
-
Desert Hope Treatment Center Launches First Responder Lifeline Program, Offering Confidential Care for Frontline Heroes
LAS VEGAS, June 18, 2026 (GLOBE NEWSWIRE) — Desert Hope Treatment Center, a leading addiction treatment center in Las Vegas, has introduced its First Responder Lifeline Program, designed specifically for law enforcement officers, firefighters, EMTs, dispatchers, corrections officers, and other public safety professionals. The program was developed in collaboration with public safety leaders, including representatives…
-
eimmigration Launches Heroes Spotlight to Recognize the Top Paralegals in Immigration Law
SAN DIEGO, June 17, 2026 (GLOBE NEWSWIRE) — eimmigration by Cerenade, the leading immigration case management software trusted by 17,000 legal professionals, today announced the launch of Heroes Spotlight: Top Paralegals in Immigration Law. The recognition program was unveiled at the American Immigration Lawyers Association (AILA) Annual Conference, where nominations officially opened. Nominations are open…
-
Resolution Therapeutics extends inflammatory and fibrotic disease pipeline with in vivo Regenerative Macrophage Therapy
Material Transfer Agreements provide access to leading lipid nanoparticle formulations to validate delivery of its proprietary payloads and accelerate development of in vivo Regenerative Macrophage Therapy Development programme complements Company’s autologous engineered Regenerative Macrophage Therapy, RTX001, in Ph 1/2 clinical development Together, programmes aim to broaden patient population able to benefit from Regenerative Macrophage Therapy…
-
AXISCADES Announces Strategic Engineering Services Divestment Program for Aerospace Engineering Services Business
This transaction completes the transformation of AXISCADES from a services-led organisation into a proprietary products and IP-focused manufacturing platform for aerospace, defence, space, electronics, semiconductors and AI. Combined with the disposal announced on 26 May 2026, the Engineering Services Divestment Program delivers success and is fully funding the Company’s Power 930 growth plan and the…
-
UCB Transforms Safety Operations with Veeva Safety Suite in Collaboration with ELIQUENT Life Sciences, Pinnaxis, and Daelight Solutions
WASHINGTON, June 12, 2026 /PRNewswire/ — ELIQUENT Life Sciences (“ELIQUENT”) today announced the June 1 go-live of Veeva Safety Suite at UCB. As one of the first organizations to adopt the complete suite, UCB is unifying its global safety operations in a transformation delivered through a strategic collaboration between Veeva, ELIQUENT, Pinnaxis, and Daelight Solutions.…
-
Press Release: Sanofi launches 2026 global employee stock purchase plan
Sanofi launches 2026 global employee stock purchase plan Paris, June 4, 2026. Sanofi’s global employee shareholder plan, Action 2026, opens on June 9, 2026, to around 75,000 employees in 52 countries. Now in its 12th year, the program demonstrates the ongoing commitment of Sanofi and its Board of Directors to involve employees in the company’s…
-
Francisco Ranzi Müller Leads the MicAi-X Technology Upgrade, Bringing Automated Trading Capabilities Into a New Cycle
SAN DIEGO, June 03, 2026 (GLOBE NEWSWIRE) — Recently, the automated trading program service platform MicAi-X has officially launched a new round of platform system upgrade plan. Founder and IT team leader Francisco Ranzi Müller will lead the relevant technical planning and system optimization efforts. This upgrade is regarded as a key milestone for MicAi-X…
-
JK Cement Strengthens Dealer Partnerships with 'Gathbandhan 2026', Rewards Top Performers with cars in Lucknow
Flagship dealer program celebrates performance, partnership, and shared growth Lucknow, Uttar Pradesh, India Reinforcing its commitment to strong dealer relationships, JK Cement hosted the latest edition of its flagship ‘Gathbandhan’ program in Lucknow, where the company rewarded 21 top-performing dealers with cars across key performance categories. JK Cement hosted the latest edition of its flagship…
-
Jersey College Offers Associate Degree for NJ Nursing Students With and Without Prior Licensure
Teterboro and Ewing campuses offer full ADN program. Next class starts August 17. June 02, 2026 10:05 ET | Source: Jersey College TETERBORO, N.J., June 02, 2026 (GLOBE NEWSWIRE) — Jersey College, the institution dedicated to excellence in nursing education, provides an Associate Degree in Nursing program at its Teterboro and Ewing, N.J., campuses, offering…
-
Gastops FluidSIGHT™ Awarded IDEaS Test Drives Contract Under Canada’s All Systems Go! Challenge
OTTAWA, ON, May 28, 2026 /PRNewswire/ — Gastops, a Canadian leader in intelligent condition monitoring and maintenance solutions, today announced it has been awarded a contract for FluidSIGHT™ under Canada’s Innovation for Defence Excellence and Security (IDEaS) program as a Test Drives participant in the All Systems Go! challenge. Test Drives enable the Department of National Defence (DND) and…
-
SkyFi Selected to Advance to NATO DIANA Mission Track
Earth intelligence platform is one of five companies to advance from a 150-company accelerator cohort to the program’s adoption-focused stage to support operational readiness across the Alliance AUSTIN, Texas, June 1, 2026 /PRNewswire/ — SkyFi, the leading Earth intelligence platform, today announced its selection to advance to the Mission Track of the North Atlantic Treaty…
-
Zealand Pharma – Transactions related to share buy-back program (week 22, 2026)
Company announcement No. 20 / 2026 Zealand Pharma – Transactions related to share buy-back program (week 22, 2026) Copenhagen, Denmark, June 1, 2026 – Zealand Pharma A/S (“the Company” or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company transforming the future of metabolic health, today reports transactions related to its share buy-back program (the…
Latest News
About the Author
We increase the awareness of millions of users through our news networks. We are one of the most trusted news networks in the world.
